An observational study of the Baska® mask: a novel supraglottic airway

Anaesthesia. 2012 Jun;67(6):640-5. doi: 10.1111/j.1365-2044.2012.07140.x.

Abstract

The Baska mask is a novel supraglottic airway device. We conducted an initial observational study to assess this device in 30 low-risk female patients. All Baska masks were inserted by a single investigator. The overall success rate for device insertion was 96.7% (95% CI 82.8-99.9%), while the success rate for the first insertion attempt was 76.7% (95% CI 57.7-90.1%). The device was easy to insert, with a mean (SD) difficulty score of 0.9 (1.6) on a 10-cm scale. The mean (SD) airway leak pressure was 35.7 (13.3) cmH(2) O. The incidence of throat pain, dysphonia and dysphagia was low. We conclude that the Baska mask demonstrates a level of utility as an alternative supraglottic airway that is worthy of further clinical study.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Airway Management / adverse effects
  • Airway Management / instrumentation*
  • Anesthesia, General
  • Body Mass Index
  • Deglutition Disorders / epidemiology
  • Deglutition Disorders / etiology
  • Disposable Equipment
  • Dysphonia / epidemiology
  • Dysphonia / etiology
  • Electrocardiography
  • Female
  • Hemodynamics / physiology
  • Humans
  • Intubation, Intratracheal / adverse effects
  • Intubation, Intratracheal / instrumentation
  • Laryngeal Masks* / adverse effects
  • Middle Aged
  • Oxygen / blood
  • Pharyngitis / epidemiology
  • Pharyngitis / etiology
  • Positive-Pressure Respiration / instrumentation
  • Postoperative Complications / epidemiology
  • Treatment Outcome

Substances

  • Oxygen